Rocket


Overview
Financials
News + Filings
Key Docs
Charts
Ownership
Insiders





All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other


Tags
Director departure
Appointed director

AILERON THERAPEUTICS INC (ALRN) Create: Alert

All | News | Filings
Date FiledTypeDescription
10/13/2023 10-Q Quarterly Report for the period ended September 30, 2023
08/11/2023 10-Q Quarterly Report for the period ended June 30, 2023
05/08/2023 10-Q Quarterly Report for the period ended March 31, 2023
04/28/2023 10-K/A Annual Report for the period ended December 31, 2022 [amend]
03/20/2023 10-K Annual Report for the period ended December 31, 2022
02/23/2023 8-K Cost Associated with Exit or Disposal Activities, Other Events  Interactive Data
Docs: "UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549"
02/14/2023 SC 13G/A BIOTECHNOLOGY VALUE FUND L P reports a 5.2% stake in Aileron Therapeutics Inc.
02/14/2023 SC 13G/A Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
11/10/2022 8-K Quarterly results
11/01/2022 10-Q Quarterly Report for the period ended September 30, 2022
08/15/2022 10-Q Quarterly Report for the period ended June 30, 2022
07/08/2022 8-K Quarterly results
06/29/2022 8-K Quarterly results
06/21/2022 424B5 Form 424B5 - Prospectus [Rule 424(b)(5)]:
06/17/2022 4 Morrison Jodie Pope (Director) has filed a Form 4 on AILERON THERAPEUTICS INC
Txns: Granted 54,500 options to buy @ $0.397, valued at $21.6k
06/17/2022 4 Form 4 - Statement of changes in beneficial ownership of securities:
06/17/2022 4 Form 4 - Statement of changes in beneficial ownership of securities:
06/17/2022 4 Sigal Nolan Howard (Director) has filed a Form 4 on AILERON THERAPEUTICS INC
Txns: Granted 54,500 options to buy @ $0.397, valued at $21.6k
06/17/2022 3 Form 3 - Initial statement of beneficial ownership of securities:
06/17/2022 4 Ambros Reinhard J. (Director) has filed a Form 4 on AILERON THERAPEUTICS INC
Txns: Granted 54,500 options to buy @ $0.397, valued at $21.6k
06/17/2022 4 Bailey Jeffrey Allen (Director) has filed a Form 4 on AILERON THERAPEUTICS INC
Txns: Granted 54,500 options to buy @ $0.397, valued at $21.6k
06/17/2022 EFFECT Form EFFECT - Notice of Effectiveness:
06/13/2022 DEL AM Form DEL AM - Delaying amendment:
06/08/2022 8-K Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing  Interact...
Docs: "UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549"
06/07/2022 8-K Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements...
Docs: "UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549"
05/05/2022 10-Q Quarterly Report for the period ended March 31, 2022
04/29/2022 DEFA14A Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
04/29/2022 DEF 14A Form DEF 14A - Other definitive proxy statements:
04/15/2022 PRE 14A Form PRE 14A - Other preliminary proxy statements:
04/15/2022 424B5 Form 424B5 - Prospectus [Rule 424(b)(5)]:
03/30/2022 4/A Aivado Manuel (See Remarks) has filed a Form 4 on AILERON THERAPEUTICS INC
Txns: Granted 1,133,000 options to buy @ $0.48, valued at $543.8k
03/30/2022 4/A Vukovic Vojo (Chief Medical Officer) has filed a Form 4 on AILERON THERAPEUTICS INC
Txns: Granted 150,000 options to buy @ $0.48, valued at $72k
03/30/2022 4/A Wanstall Rick (See Remarks) has filed a Form 4 on AILERON THERAPEUTICS INC
Txns: Granted 393,000 options to buy @ $0.48, valued at $188.6k
03/30/2022 4/A Annis Allen (SVP, Research) has filed a Form 4 on AILERON THERAPEUTICS INC
Txns: Granted 313,000 options to buy @ $0.48, valued at $150.2k
  Next >>

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy